Statistics from Altmetric.com
A 43-year-old woman, known to have bipolar disorder, presented with 4 months history of change in behaviour and functional status in addition to memory problem. Lately she started to have constant headache, fatigue and multiple episodes of postural syncope. This was associated with nausea, vomiting and weight loss. Her family doctor attributed her symptoms to bipolar disease without seeking further tests. She has a history of 30-pack-year tobacco smoking. Physical examination was remarkable for lethargy, flat affect, in addition to cognition and orientation impairment. The rest of her examination was unremarkable. Head CT scan showed multiple large heterogeneous hypodensities in both frontal lobes. Brain MRI demonstrated large bilateral frontal cystic and solid lesions, consistent with metastatic lesions (figure 1). These lesions were symmetrical around the midline and precluded subfalcine herniation. CT scan of chest abdomen and pelvis showed right lung apex (Pancoast tumour) mass with mediastinal lymphadenopathy (figure 2). Adrenal and liver lesions were detected as well. This was sufficient to stage the tumour and no positron emission tomography scan was performed. CT-guided biopsy of the lung mass was obtained and pathology examination declared poorly differentiated lung adenocarcinoma. TNM score was determined to be T3N2M1 based on imaging and histopathological findings. She underwent 14 sessions of radiation and systemic steroids, which led to partial recovery in her decision-making capacity. Disease extension and prognosis was discussed with the patient and she opted for hospice care only. After 5 weeks, the patient expired at home. In retrospect, it is obvious that she had precocious and unspecific features masquerading as her bipolar disorder. This was very misleading and, therefore, resulted in major delay in diagnosis and early interventions required to increase survival and improve quality of life.1–3
Cystic brain metastases arising from lung adenocarcinoma is very rare.
Patients presenting with new or worsening neuropsychiatric symptoms should be worked up based on risk stratification for malignancy, infections and degenerative brain processes.
Synchronous presentation of brain metastasis comprises less than 20% in patients with cancer.
Competing interests None.
Patient consent Obtained.
Provenance and peer review Not commissioned; externally peer reviewed.
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.